Edition:
United States

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

9.47USD
16 Feb 2018
Change (% chg)

$0.07 (+0.74%)
Prev Close
$9.40
Open
$9.42
Day's High
$9.58
Day's Low
$9.35
Volume
21,816
Avg. Vol
40,509
52-wk High
$10.80
52-wk Low
$5.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 9.03 -0.135
Jun '17 8.94 -0.192
Mar '17 8.23 -0.125
FY 2016 Dec '16 4.89 -0.160
Sep '16 4.25 -0.148
Jun '16 2.80 -0.218
Mar '16 0.00 -0.344
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 10.00 10.00 10.00 --
Quarter Ending Jun-18 1 10.00 10.00 10.00 --
Year Ending Dec-18 3 38.40 40.00 36.00 22.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.25 -0.24 -0.26 --
Quarter Ending Jun-18 2 -0.29 -0.28 -0.30 --
Year Ending Dec-18 3 -1.06 -0.73 -1.25 -0.85
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.03 34.43
P/E High - Last 5 Yrs. -- 41.47 46.75
P/E Low - Last 5 Yrs. -- 23.35 24.14
Beta 1.93 0.81 0.81
Price to Sales (TTM) 14.84 6.26 8.57
Price to Book (MRQ) 12.38 4.27 5.14
Price to Tangible Book (MRQ) 12.37 4.76 6.30
Price to Cash Flow (TTM) -- 22.77 25.75
% Owned Institutions 50.15 1.27 2.33

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.26 5.27
Payout Ratio(TTM) -- 45.36 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 112.40 8.53 9.45
Sales (TTM) vs TTM 1 Yr. Ago 341.17 6.35 7.30
Sales - 5 Yr. Growth Rate -17.73 9.90 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 8.84 16.64 20.15
EPS (TTM) vs TTM 1 Yr. Ago 37.15 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.48
Capital Spending - 5 Yr. Growth Rate 12.86 14.63 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.38 2.42
Current Ratio (MRQ) 2.76 3.33 3.38
LT Debt to Equity (MRQ) 0.00 8.98 11.85
Total Debt to Equity (MRQ) 0.00 12.06 15.12
Interest Coverage (TTM) -- 44.83 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.25 54.90
Gross Margin - 5 Yr. Avg. -- 52.61 52.64
EBITD Margin (TTM) -97.53 -- --
EBITD - 5 Yr. Avg -905.51 18.52 9.86
Operating Margin (TTM) -98.81 11.43 1.25
Operating Margin - 5 Yr. Avg. -916.34 14.30 5.07
Pre-Tax Margin (TTM) -94.78 11.82 2.12
Pre-Tax Margin - 5 Yr. Avg. -908.69 14.58 5.33
Net Profit Margin (TTM) -94.78 8.21 -1.38
Net Profit Margin - 5 Yr. Avg. -908.69 10.92 1.62
Effective Tax Rate (TTM) -- 22.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 23.57 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 501,371 919,747,049 819,569,446
Net Income/Employee (TTM) -475,177 107,578,762 95,804,981
Receivable Turnover (TTM) 95.65 5.29 5.40
Inventory Turnover (TTM) -- 2.59 3.48
Asset Turnover (TTM) 0.24 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.52 11.11 10.68
Return on Assets - 5 Yr. Avg. -35.54 12.64 12.00
Return on Investment (TTM) -30.83 14.00 13.54
Return on Investment - 5 Yr. Avg. -39.19 16.55 15.72
Return on Equity (TTM) -64.29 15.34 14.80
Return on Equity - 5 Yr. Avg. -42.58 17.61 16.91
  1 Year 3 Year 5 Year
Sales % -- 25.35 -17.73
EPS (TTM) % 20.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ChemoCentryx Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.41 16.65 91 52
13 Week 29.37 22.11 81 42
26 Week 37.85 22.37 78 18
52 Week 38.65 19.12 77 28
YTD 59.16 55.75 97 35
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.15%
# of Holders: 132
Total Shares Held: 24,456,941
3 Mo. Net Change: 45,418
# New Positions: 11
# Closed Positions: 8
# Increased Positions: 51
# Reduced Positions: 40
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.